Digestibility of Different Plant-based Proteins in Humans With Ileostomy
PAN-Prodig
True Ileal Digestibility of Different Plant-based Proteins in a Human Ileostomy Model
1 other identifier
interventional
11
1 country
1
Brief Summary
The goal of this interventional study is to learn about the digestibility of different plant-based proteins in adults (age 18-75) with an ileostomy. The main questions the study aims to answer are:
- 1.How does the digestibility of proteins in the small intestine differ between different plant-based proteins?
- 2.Which proteins and amino acids are not digested or absorbed in the small intestine and are available for further metabolic processes in the large intestine?
- 3.How do metabolites in the collected content of the ileostomy bag differ after consuming different plant-based proteins?
- 4.Can the in vivo results be compared to results from existing in vitro models?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2023
CompletedFirst Posted
Study publicly available on registry
November 21, 2023
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedAugust 14, 2025
August 1, 2025
7 months
November 15, 2023
August 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
True ileal digestibility of different plant-based proteins
The primary outcome is defined as the differences in the true ileal digestibility, determined by measuring the amount of nitrogen in the meal and the amount of unabsorbed nitrogen in the ileal fluid after consuming four different plant-based protein meals
0-5 hours after consumption of test meal (on all 5 study days)
Secondary Outcomes (2)
Protein and metabolite profiles in ileostomy digesta
0-5 hours after consumption of test meal (on all 5 study days)
Differences between in vivo and in vitro data
In vivo data: 0-5 hours after consumption of test meal (on all 5 study days)
Study Arms (11)
Dietary Intervention Sequence 1 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))
EXPERIMENTALThe participant will consume the below mentioned meals in a random order on five different study days (one on each visit): * Protein meal: pea protein, low bioavailability * Protein meal: pea protein, high bioavailability * Protein meal: oat protein, low bioavailability * Protein meal: oat protein, high bioavailability * Protein-free meal
Dietary Intervention Sequence 2 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))
EXPERIMENTALThe participant will consume the below mentioned meals in a random order on five different study days (one on each visit): * Protein meal: pea protein, low bioavailability * Protein meal: pea protein, high bioavailability * Protein meal: oat protein, low bioavailability * Protein meal: oat protein, high bioavailability * Protein-free meal
Dietary Intervention Sequence 3 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))
EXPERIMENTALThe participant will consume the below mentioned meals in a random order on five different study days (one on each visit): * Protein meal: pea protein, low bioavailability * Protein meal: pea protein, high bioavailability * Protein meal: oat protein, low bioavailability * Protein meal: oat protein, high bioavailability * Protein-free meal
Dietary Intervention Sequence 4 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))
EXPERIMENTALThe participant will consume the below mentioned meals in a random order on five different study days (one on each visit): * Protein meal: pea protein, low bioavailability * Protein meal: pea protein, high bioavailability * Protein meal: oat protein, low bioavailability * Protein meal: oat protein, high bioavailability * Protein-free meal
Dietary Intervention Sequence 5 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))
EXPERIMENTALThe participant will consume the below mentioned meals in a random order on five different study days (one on each visit): * Protein meal: pea protein, low bioavailability * Protein meal: pea protein, high bioavailability * Protein meal: oat protein, low bioavailability * Protein meal: oat protein, high bioavailability * Protein-free meal
Dietary Intervention Sequence 6 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))
EXPERIMENTALThe participant will consume the below mentioned meals in a random order on five different study days (one on each visit): * Protein meal: pea protein, low bioavailability * Protein meal: pea protein, high bioavailability * Protein meal: oat protein, low bioavailability * Protein meal: oat protein, high bioavailability * Protein-free meal
Dietary Intervention Sequence 7 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))
EXPERIMENTALThe participant will consume the below mentioned meals in a random order on five different study days (one on each visit): * Protein meal: pea protein, low bioavailability * Protein meal: pea protein, high bioavailability * Protein meal: oat protein, low bioavailability * Protein meal: oat protein, high bioavailability * Protein-free meal
Dietary Intervention Sequence 8 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))
EXPERIMENTALThe participant will consume the below mentioned meals in a random order on five different study days (one on each visit): * Protein meal: pea protein, low bioavailability * Protein meal: pea protein, high bioavailability * Protein meal: oat protein, low bioavailability * Protein meal: oat protein, high bioavailability * Protein-free meal
Dietary Intervention Sequence 9 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))
EXPERIMENTALThe participant will consume the below mentioned meals in a random order on five different study days (one on each visit): * Protein meal: pea protein, low bioavailability * Protein meal: pea protein, high bioavailability * Protein meal: oat protein, low bioavailability * Protein meal: oat protein, high bioavailability * Protein-free meal
Dietary Intervention Sequence 10 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))
EXPERIMENTALThe participant will consume the below mentioned meals in a random order on five different study days (one on each visit): * Protein meal: pea protein, low bioavailability * Protein meal: pea protein, high bioavailability * Protein meal: oat protein, low bioavailability * Protein meal: oat protein, high bioavailability * Protein-free meal
Dietary Intervention Sequence 11 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))
EXPERIMENTALThe participant will consume the below mentioned meals in a random order on five different study days (one on each visit): * Protein meal: pea protein, low bioavailability * Protein meal: pea protein, high bioavailability * Protein meal: oat protein, low bioavailability * Protein meal: oat protein, high bioavailability * Protein-free meal
Interventions
Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein-free meal to correct analyses for endogenous protein losses.
Eligibility Criteria
You may qualify if:
- Age: 18 - 75 years
- Body mass index: 18.5 - 30 kg/m2
- (double-loop) Ileostomy with an intact small bowel
- Signed informed consent
You may not qualify if:
- Pregnancy or breastfeeding
- Ileostomy \< 3 months before the study
- Any clinically significant present or past disease/condition other than colon cancer which in the investigator's opinion could interfere with the results of the trial
- Any clinically significant present or past medication which in the investigator's opinion could interfere with the results of the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Örebro University
Örebro, 70182, Sweden
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2023
First Posted
November 21, 2023
Study Start
September 1, 2025
Primary Completion
April 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
August 14, 2025
Record last verified: 2025-08